Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001797826-26-000006

Director sold 11,439 shares at an average $22.90 ($261,929)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Thornberry Nancy · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-02 Sale : show line 1 in the form 10b5-1 −10,824 $22.85 $247,328 20,301 D
2026-09-02 Sale : show line 2 in the form 10b5-1 −615 $23.74 $14,600 19,686 D
Open-market sales · 11,439 sh · avg $22.90 · $261,929
Loading xslF345X06/wk-form4_1788555742.xml…